Hearing status in children with congenital cytomegalovirus: Up-to-6-years audiological follow-up

International Journal of Pediatric Otorhinolaryngology

Volumn 75, Issue 3, 2011, Pages 376-382

  Royackers, Liesbeth ^a   Christian, Desloovere ^a   Frans, Debruyne ^a   Ermelinde, Rector ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cytomegalovirus; Ganciclovir; Hearing loss

Indexed keywords

GANCICLOVIR;

ARTICLE; ASYMPTOMATIC DISEASE; AUDIOLOGY; AUDIOMETRY; AUDITORY SCREENING; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; FEMALE; FOLLOW UP; HEARING LOSS; HEARING TEST; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ANTIVIRAL AGENTS; AUDIOMETRY, PURE-TONE; AUDITORY THRESHOLD; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GANCICLOVIR; HEARING LOSS, SENSORINEURAL; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES;

EID: 79951514307     PISSN: 01655876     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijporl.2010.12.008     Document Type: Article

References (22)

1. Foulon I., Naessens A., Foulon W., Casteels A., Gordts F. A 10-year prospective study of sensorineural hearing loss in children with congenital cytomegalovirus infection. J. Pediatr. 2008, 153:84-88.
2. Fowler K.B., McCollister F.P., Dahle A.J., Boppana S.B., Britt W.J., Pass R.F. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J. Pediatr. 1997, 130:624-630.
3. Nance W.E., Lim B.G., Dodson K.M. Importance of congenital cytomegalovirus infections as a cause of pre-lingual hearing loss. J. Clin. Virol. 2006, 35:221-225.
4. Fowler K.B., Boppana S.B. Congenital cytomegalovirus (CMV) infection and hearing deficit. J. Clin. Virol. 2006, 35:226-231.
5. Madden C., Wiley S., Schleiss M., Benton C., Meinzen-Derr J., Greinwald J., et al. Audiometric, clinical and educational outcomes in a pediatric symptomatic congenital cytomegalovirus (CMV) population with sensorineural hearing loss. Int. J. Pediatr. Otorhinolaryngol. 2005, 69:1191-1198.
6. Kimberlin D.W., Lin C.-Y., Sanchez P.J., Demmler G.J., Dankner W., Shelton M., et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J. Pediatr. 2003, 143:16-25.
7. Smets K., De Coen K., Dhooghe I., Standaert L., Laroche S., Mahieu L., et al. Selecting neonates with congenital cytomegalovirus infection for ganciclovir therapy. Eur. J. Pediatr. 2006, 165:885-890.
8. Lackner A., Acham A., Alborno T., Moser M., Engele H., Raggam R.B., et al. Effect on hearing of ganciclovir therapy for asymptomatic cytomegalovirus infection: four to 10 years follow up. J. Laryngol. Otol. 2009, 123:391-396.
9. Verhaert N., Willems M., Van Kerschaver E., Desloovere C. Impact of early screening and treatment on language development and education level: evaluation of 6 years of universal newborn hearing screening (ALGO) in Flanders, Belgium. Int. J. Pediatr. Otorhinolaryngol. 2008, 72:599-608.
10. Van Kerschaver E., Boudewyns A.N., Stappaerts L., Wuyts F.L., Van de Heyning P.H. Organisation of a newborn hearing screening: are we achieving the Joint Committee on Infant Hearing (JCIH) objectives?. Laryngoscope 2005, 115:232-236.
11. John M.S., Picton T.W. MASTER: a window program for recording multiple auditory steady-state responses. Comput. Methods Programs Biomed. 2000, 61:125-150.
12. Luts H., Desloovere C., Wouters J. Clinical application of dichotic multiple-stimulus auditory steady-state responses in high-risk newborns and young children. Audiol. Neurol. 2006, 11:24-37.
13. Verbeke G., Molenberghs G. Linear Mixed Models for Longitudinal Data 2000, Springer-Verlag, New York.
14. Pass R.F. Congenital cytomegalovirus infection and hearing loss. Herpes 2005, 12:50-55.
15. Grosse S.D., Ross D.S., Dollard S.C. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J. Clin. Virol. 2008, 41:57-62.
16. Dahle A.J., Fowler K.B., Wright J.D. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J. Am. Acad. Audiol. 2000, 11:283-290.
17. Prober C.G., Enright A.M. Congenital cytomegalovirus (CMV) infection: hats off to Alabama. J. Pediatr. 2003, 143:4-6.
18. Boppana S.B., Fowler K.B., Pass R.F., Riviera L.B., Bradford R., Lakeman F.D., et al. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J. Pediatr. 2005, 146:817-823.
19. Amir J., Wolf D.G., Levy I. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir. Eur. J. Pediatr. 2010, 169:1061-1067.
20. Michaels M.G., Greenberg D.P., Sabo D.L., Wald E.R. Treatment of children with congenital cytomegalovirus infection with ganciclovir. Pediatr. Infect. Dis. J. 2003, 22:504-508.
21. Kimberlin D.W., Acosta E.P., Sánchez P.J., Sood S., Agrawal V., Homans J., et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J. Infect. Dis. 2008, 197:836-845.
22. National Institute of Allergy and Infectious Diseases. Valganciclovir in Congenital CMV infants. Updated August 1, 2010. Accessed August 4, 2010. http://clinicaltrials.gov/ct/show/NCT0031434.